Clinical trial
Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis
NCT00222534 · University of Oslo School of Pharmacy, Other · Completed
Key facts
| NCT number | NCT00222534 |
|---|---|
| Title | Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis |
| Official title | Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis |
| Lead sponsor | University of Oslo School of Pharmacy, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Respiratory Insufficiency, Alkalosis |
| Intervention type | Drug |
| Interventions | Acetazolamide, Placebo |
| Enrollment | 70 |
| Start date | Jan 1, 2002 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 20, 2014 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: